Medicare

The Centers for Medicare & Medicaid Services (CMS) should withdraw its proposal to reduce Medicare Part B payment for drugs acquired through the 340B Drug Pricing Program, AHA yesterday told the agency in comments on its outpatient prospective payment system proposed rule for calendar year 2018鈥
The Centers for Medicare & Medicaid Services should withdraw its proposal to reduce Medicare Part B payment for drugs acquired through the 340B Drug Pricing Program, AHA today told the agency in comments on its outpatient prospective payment system proposed rule for calendar year 2018. 鈥淐MS鈥
The AHA today expressed serious concerns with the Centers for Medicare & Medicaid Services鈥 proposal to significantly reduce the payment rate for 鈥渘onexcepted鈥 services provided in off-campus provider-based departments under the physician fee schedule proposed rule for calendar year 2018.
The Centers for Medicare & Medicaid Services has released an online training course for state survey agencies that will evaluate compliance with new emergency preparedness requirements for hospitals and other providers beginning Nov. 15. The course also is available to providers.
As urged by the AHA and others, a Centers for Medicare & Medicaid Services advisory panel today recommended that the agency not finalize for 2018 a proposal that would drastically cut Medicare payments for drugs acquired under the 340B Drug Pricing Program. In July, CMS proposed to pay鈥
The Health Resources and Services Administration has provided an update on its new 340B Office of Pharmacy Affairs Information System, which includes a new registration system and a new secure pricing system. HRSA said the registration component of the new 340B OPAIS will be released in mid-鈥
The Health Resources and Services Administration today proposed delaying until July 1, 2018 the effective date of its final rule on 340B drug ceiling prices and civil monetary penalties for manufacturers. The final rule has been subject to multiple delays since January, and most鈥
CMS Aug. 15 proposed to cancel the cardiac and surgical hip and femur fracture treatment (SHFFT) bundled payment models. Details of the proposed rule follow.